153 related articles for article (PubMed ID: 35563019)
1. The Use of Molecular Dynamics Simulation Method to Quantitatively Evaluate the Affinity between HBV Antigen T Cell Epitope Peptides and HLA-A Molecules.
Mei X; Li X; Zhao C; Liu A; Ding Y; Shen C; Li J
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563019
[TBL] [Abstract][Full Text] [Related]
2. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848
[TBL] [Abstract][Full Text] [Related]
3. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen.
Chung MK; Yoon H; Min SS; Lee HG; Kim YJ; Lee TG; Lim JS; Kim CM; Park SN
J Immunother; 1999 Jul; 22(4):279-87. PubMed ID: 10404429
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.
de Beijer MTA; Jansen DTSL; Dou Y; van Esch WJE; Mok JY; Maas MJP; Brasser G; de Man RA; Woltman AM; Buschow SI
J Virol; 2020 Mar; 94(7):. PubMed ID: 31852786
[TBL] [Abstract][Full Text] [Related]
5. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
6. Screening and Identification of HBV Epitopes Restricted by Multiple Prevalent HLA-A Allotypes.
Ding Y; Zhou Z; Li X; Zhao C; Jin X; Liu X; Wu Y; Mei X; Li J; Qiu J; Shen C
Front Immunol; 2022; 13():847105. PubMed ID: 35464415
[TBL] [Abstract][Full Text] [Related]
7. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.
Liu Q; Zheng Y; Yu Y; Tan Q; Huang X
Int Immunopharmacol; 2012 Jun; 13(2):141-7. PubMed ID: 22480777
[TBL] [Abstract][Full Text] [Related]
8. In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana.
Choga WT; Anderson M; Zumbika E; Phinius BB; Mbangiwa T; Bhebhe LN; Baruti K; Kimathi PO; Seatla KK; Musonda RM; Bell TG; Moyo S; Blackard JT; Gaseitsiwe S
Viruses; 2020 Jul; 12(7):. PubMed ID: 32640609
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
Bertoletti A; Costanzo A; Chisari FV; Levrero M; Artini M; Sette A; Penna A; Giuberti T; Fiaccadori F; Ferrari C
J Exp Med; 1994 Sep; 180(3):933-43. PubMed ID: 7520476
[TBL] [Abstract][Full Text] [Related]
10. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
[TBL] [Abstract][Full Text] [Related]
11. Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51.
Thimme R; Chang KM; Pemberton J; Sette A; Chisari FV
J Virol; 2001 Apr; 75(8):3984-7. PubMed ID: 11264388
[TBL] [Abstract][Full Text] [Related]
12. CD8
Zhang Y; Wu Y; Deng M; Xu D; Li X; Xu Z; Hu J; Zhang H; Liu K; Zhao Y; Gao F; Bi S; Gao GF; Zhao J; Liu WJ; Meng S
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950410
[TBL] [Abstract][Full Text] [Related]
13. An in silico study to unveil potential drugs and vaccine chimera for HBV capsid assembly protein: combined molecular docking and dynamics simulation approach.
Ismail S; Waheed Y; Ahmad S; Ahsan O; Abbasi SW; Sadia K
J Mol Model; 2022 Feb; 28(2):51. PubMed ID: 35112241
[TBL] [Abstract][Full Text] [Related]
14. In Silico Analysis of Epitope-Based Vaccine Candidates against Hepatitis B Virus Polymerase Protein.
Zheng J; Lin X; Wang X; Zheng L; Lan S; Jin S; Ou Z; Wu J
Viruses; 2017 May; 9(5):. PubMed ID: 28509875
[TBL] [Abstract][Full Text] [Related]
15. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8+ T-cell responses in HLA-A2.1/Kb transgenic mice.
Zhang Y; Li S; Shan M; Pan X; Zhuang K; He L; Gould K; Tien P
Immunology; 2007 May; 121(1):105-12. PubMed ID: 17244158
[TBL] [Abstract][Full Text] [Related]
17. Identification and functional studies of HLA-A0201 restricted CTL epitopes in the X protein of hepatitis B virus.
Guo YJ; Zhu Y; Sun SH
Acta Virol; 2011; 55(2):107-15. PubMed ID: 21692558
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.
Brinck-Jensen NS; Vorup-Jensen T; Leutscher PD; Erikstrup C; Petersen E
BMC Immunol; 2015 Nov; 16():65. PubMed ID: 26526193
[TBL] [Abstract][Full Text] [Related]
19. The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope.
Liu HG; Chen WW; Fan ZP; Yang HY; Shi M; Zhang Z; Luan SS; Zhang H; Lu P; Tien P; Wang FS
Clin Immunol; 2007 Dec; 125(3):337-45. PubMed ID: 17900990
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals.
Khakoo SI; Ling R; Scott I; Dodi AI; Harrison TJ; Dusheiko GM; Madrigal JA
Gut; 2000 Jul; 47(1):137-43. PubMed ID: 10861276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
